{
    "2020-08-05": [
        [
            {
                "time": "",
                "original_text": "兴证医药2020年8月投资月报：再论大创新时代的创新疫苗",
                "features": {
                    "keywords": [
                        "兴证医药",
                        "创新疫苗",
                        "大创新时代"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国元医药】新冠疫苗/中和抗体动态跟踪 &  7月疫苗批签发数据跟踪",
                "features": {
                    "keywords": [
                        "国元医药",
                        "新冠疫苗",
                        "中和抗体",
                        "批签发数据",
                        "7月"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}